Assisted Recovery Centers of America, LLC (ARCA) Market Research Report

Background

Overview

Assisted Recovery Centers of America (ARCA), established in 2001, is a behavioral health organization headquartered in St. Louis, Missouri. The company specializes in providing a comprehensive continuum of integrated services to adult patients with substance use and other behavioral disorders. ARCA's mission is to promote healing and thriving for individuals, families, and communities through compassionate and innovative care.

Mission and Vision

ARCA is dedicated to partnering with patients and their loved ones to help them lead rewarding, prosperous lives by building on their assets, skills, and capabilities. The organization emphasizes a science-based approach, whole-person care, and integrated dual diagnosis treatment to address both substance use and co-occurring mental health disorders.

Industry Significance

As a leader in addiction medicine, ARCA plays a crucial role in the mental health and addiction treatment sector, particularly in the St. Louis area. The organization has been recognized for its commitment to evidence-based treatments and its efforts to reduce recidivism within the criminal justice system.

Key Strategic Focus

Core Objectives

ARCA aims to provide individualized treatment plans that address the biological, psychological, and social aspects of addiction and mental health, ensuring that each patient's unique needs are met. The organization focuses on outpatient care to support recovery within the patient's natural environment, allowing individuals to maintain daily responsibilities while receiving structured support.

Areas of Specialization

ARCA specializes in treating substance use disorders and co-occurring mental health conditions through a combination of medication-assisted treatment (MAT) and behavioral therapies. The organization also offers services such as medical detoxification, psychiatric care, peer support, case management, and transitional living programs.

Key Technologies Utilized

ARCA employs evidence-based medical research, particularly in the use of FDA-approved medications like Naltrexone (Vivitrol®), Buprenorphine, and Methadone, combined with behavioral therapies to effectively treat substance use and co-occurring mental health disorders.

Primary Markets and Conditions Targeted

The organization primarily serves adults in the St. Louis area and throughout Missouri, focusing on individuals struggling with substance use disorders and co-occurring mental health conditions. ARCA operates two outpatient treatment locations in the greater St. Louis area and collaborates with 27 telehealth sites across Missouri.

Financials and Funding

Funding History

Specific details regarding ARCA's total funds raised and recent funding rounds are not publicly disclosed. The organization operates as a privately held entity, and financial information is limited.

Notable Investors

Information about individual investors or investment firms involved with ARCA is not publicly available.

Utilization of Capital

While specific utilization details are not disclosed, it is reasonable to infer that ARCA invests in expanding its treatment facilities, enhancing service offerings, and supporting community outreach programs to fulfill its mission.

Pipeline Development

Key Pipeline Candidates

ARCA's primary focus is on providing outpatient treatment programs for substance use and behavioral health disorders. The organization does not publicly disclose specific pipeline candidates or product development stages.

Stages of Clinical Trials or Product Development

As a treatment provider, ARCA does not engage in clinical trials or product development. Instead, the organization focuses on delivering evidence-based treatment services to its patients.

Target Conditions

ARCA targets substance use disorders and co-occurring mental health conditions, offering comprehensive treatment programs to address these challenges.

Anticipated Milestones

Specific timelines for anticipated milestones are not publicly disclosed. However, ARCA continues to expand its services and collaborate with community partners to enhance care delivery.

Technological Platform and Innovation

Proprietary Technologies

ARCA utilizes FDA-approved medications such as Naltrexone (Vivitrol®), Buprenorphine, and Methadone, integrated with behavioral therapies, to effectively treat substance use and co-occurring mental health disorders.

Significant Scientific Methods

The organization employs a science-based approach grounded in evidence-based medical research, focusing on individualized treatment plans that address the unique needs of each patient.

Leadership Team

Key Executive Profiles

• Percy Menzies: President & Founder. Percy has over 18 years of experience with DuPont Pharmaceuticals, including serving as associate product director for naltrexone. He has worked closely with drug courts and provided training on the use of anti-craving medications for addiction. Percy holds a master’s degree in pharmacy.

• Suneal Menzies: Chief Operating Officer. With over 16 years of leadership experience in mental health and substance use disorder treatment, Suneal has held strategic advisory roles across public and private sectors, contributing to transformative initiatives in behavioral health.

• Richard Scholz: Chief Financial Officer. Richard manages the financial actions of the company, including tracking cash flow and financial planning. He has been part of ARCA for 8 years and has developed full life cycle processes for addiction treatment.

• Dr. Fred Rottnek: Chief Medical Officer. Dr. Rottnek graduated from the Saint Louis University School of Medicine and completed his family medicine residency at Family Medicine of Saint Louis. He has a deep interest in the intersection of neurobiology and substance use disorders.

• Dr. Ingrid Clarke: Medical Director. Dr. Clarke is board-certified in Addiction Medicine and has a diverse background in emergency medicine and integrative medicine. She joined ARCA as a provider in 2020 and became Medical Director in 2023.

• Laura Williams: Director of Nursing. With over 20 years of clinical and leadership experience, Laura oversees all nursing operations at ARCA, including nursing assessments, medication management, and detox protocols.

• Mitch Ackerman: Director of Behavioral Health. Mitch has extensive experience in mental health care, leadership, and program development, focusing on delivering comprehensive mental health and substance use services.

• Briana Gibb: Systems Administrator. Briana has worked in substance use treatment since 2013 and has developed and implemented several state programs, partnerships, and the opening of additional clinics with high standards of patient care.

• Christina Syberg: Operations Manager / HR Generalist. Christina has over a decade of experience in nonprofit leadership and is committed to advocating for marginalized individuals. She currently serves as the Operations Manager and HR Generalist at ARCA.

• Jordan Hampton: Director of Housing. Jordan is a person in long-term recovery with a background of lived experience through substance misuse and ARCA’s recovery housing program.

Competitor Profile

Market Insights and Dynamics

The addiction treatment industry is experiencing significant growth due to increasing awareness of mental health and substance use disorders. Organizations like ARCA are expanding their services to meet the rising demand for comprehensive, outpatient treatment programs.

Competitor Analysis

Key competitors in the region include:

• Recovery Centers of America (RCA): Founded in 2015, RCA operates a network of inpatient and outpatient facilities across the United States, offering a full continuum of care for substance use and mental health disorders.

• JourneyPure: Established in 2014, JourneyPure operates residential rehabs and outpatient clinics in Tennessee, Kentucky, and Florida, focusing on treating substance use disorders and mental health conditions.

• Wellpath: Formerly known as Correct Care Solutions, Wellpath is a healthcare company based in Nashville, Tennessee, providing services in both the United States and Australia, including addiction treatment and mental health services.

Strategic Collaborations and Partnerships

ARCA collaborates with community partners to provide compassionate and innovative care, promoting healing and thriving for individuals, families, and communities.

Operational Insights

ARCA's focus on outpatient care allows individuals to maintain daily responsibilities while receiving structured support, differentiating it from competitors that may offer inpatient services.